Philip Morris fights to acquire a medical inhaler company


Read the transcript of this episode on FT.com

https://www.ft.com/content/b20cdab3-2e47-4bbe-bbff-39c42459d105

The pace of rising consumer prices in the United States in recent months will stagnate near a 13-year high in July, and SoftBank will cut its investment in Chinese start-ups until Beijing’s scrutiny of the technology industry becomes clear. In addition, private capital reporter Kaye Wiggins of the Financial Times provided the latest news on the battle between private equity group Carlyle and tobacco company Philip Morris International for the British medical inhaler manufacturer Vectura.

U.S. consumer price increases are expected to slow

https://www.ft.com/content/8a2ad340-5ecf-4aa5-be35-aa7f528c8b83

Carlyle withdraws from bidding war between Vectura and Philip Morris

https://www.ft.com/content/9b860f52-ddf7-447b-bd74-c44b25a69da7

SoftBank will cut its investment in China until the technology industry calms down

https://www.ft.com/content/8b98db7c-24e9-4aa4-bc42-56338139962e

The elusive Olympic rebound gives hope to Suga’s leading competitor

https://www.ft.com/content/47557c29-2225-4501-81dd-df4b41220725?

The FT news briefing was produced by Fiona Symon and Marc Filippino. The editor of the show is Jess Smith. Our intern is Zoe Han. Additional help from Gavin Kallmann, Michael Bruning and Persis Love. The theme song of the show is metaphorical music. The head of global audio for the Financial Times is Cheryl Brumley.


Look acast.com/privacy Privacy and opt-out information.

Transcripts for this podcast are currently unavailable. View our accessibility guide.



Source link